Ajardy M 5 mg+500 mg (Tablet)

Unit Price: ৳ 15.00 (4 x 8: ৳ 480.00)
Strip Price: ৳ 120.00

Medicine Details

Indications

  • Treatment of type 2 diabetes mellitus in adults
  • Adjunct to diet and exercise
  • Use in patients insufficiently controlled on maximally tolerated dose of Metformin alone
  • Use in combination with other medicinal products for diabetes
  • Use in patients already being treated with the combination of Empagliflozin and Metformin separately

Pharmacology

  • Inhibitor of Sodium-Glucose Co-Transporter 2 (SGLT2)
  • Reduction of renal reabsorption of filtered glucose
  • Lowering of renal threshold for glucose
  • Increase in urinary glucose excretion
  • Biguanide type oral antihyperglycemic drug
  • Lowers both basal and postprandial plasma glucose
  • Does not produce hypoglycemia
  • Decreases hepatic glucose production
  • Decreases intestinal absorption of glucose
  • Improves insulin sensitivity

Dosage & Administration

  • Individualized based on effectiveness and tolerability
  • Twice daily with meals
  • Gradual dose escalation to reduce gastrointestinal side effects
  • Maximum recommended daily doses of Metformin Hydrochloride and Empagliflozin
  • Extended-release formulations available
  • Dosing adjustment for renal impaired patients
  • Not recommended for pediatric patients under 18 years of age

Interaction

  • Diuretics
  • Insulin or Insulin Secretagogues
  • Positive Urine Glucose Test
  • Drugs that Reduce Metformin Clearance
  • Carbonic Anhydrase Inhibitors
  • Drugs Affecting Glycemic Control
  • Alcohol

Contraindications

  • Hypersensitivity to Empagliflozin and Metformin
  • Acute metabolic acidosis
  • Diabetic pre-coma
  • Severe renal failure
  • Acute conditions altering renal function
  • Conditions causing tissue hypoxia
  • Hepatic impairment
  • Acute alcohol intoxication
  • Alcoholism

Side Effects

  • Urinary tract infection
  • Female genital mycotic infections
  • Diarrhea
  • Nausea/vomiting
  • Flatulence
  • Abdominal discomfort
  • Indigestion
  • Asthenia
  • Headache
  • Hypoglycemia
  • Vaginal moniliasis
  • Vulvovaginitis
  • Balanitis
  • Urinary tract infection
  • Thirst
  • Taste disturbance
  • Pruritus
  • Rash
  • Increased urination
  • Increased serum lipids
  • Volume depletion
  • Urticaria
  • Dysuria
  • Increased blood creatinine/Glomerular filtration rate
  • Increased haematocrit
  • Diabetic ketoacidosis

Pregnancy & Lactation

  • Potential risk to fetus
  • Not recommended during breastfeeding

Precautions & Warnings

  • Lactic Acidosis
  • Hypotension
  • Ketoacidosis
  • Acute kidney injury & impairment in renal function
  • Urosepsis, Pyelonephritis, Fournier's gangrene & Genital mycotic infections
  • Hypoglycemia
  • Vitamin B12 Deficiency
  • Increased LDL-C
  • Macrovascular Outcomes

Overdose Effects

  • No toxicity seen with single/multiple doses of Empagliflozin
  • Hypoglycemia not seen with Metformin
  • Lactic acidosis a medical emergency
  • Treatment should be initiated based on clinical status
  • Haemodialysis for removal of lactate and Metformin

Therapeutic Class

  • Combination Oral hypoglycemic preparations

Storage Conditions

  • Keep below 30°C temperature
  • Protected from light & moisture
  • Keep out of the reach of children

Related Brands